Evidence map›Paper›PMID 28150070›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2017

Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG.

Kozo Kataoka, Takahiro Kinoshita, Markus Moehler, Murielle Mauer, Kohei Shitara, Anna Dorothea Wagner, Stefanie Schrauwen, Takaki Yoshikawa, Franco Roviello, Masanori Tokunaga and 5 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Chemotherapy for advanced gastric cancer.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Article
  7. Review
  8. Practical management of oligometastatic gastric cancer.ESMO gastrointestinal oncology · 2024
    Review
  9. Article
  10. Article
  11. German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 6 countries.

Kozo KataokaEuropean Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue E, Mounier 83/11, 1200, Brussels, Belgium. kozokataoka@hotmail.co.jp.ORCID http://orcid.org/0000-0003-2043-8184
Takahiro KinoshitaDepartment of Gastric Surgery Division, National Cancer Center Hospital East, Chiba, Japan.
Markus MoehlerFirst Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Murielle MauerEuropean Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue E, Mounier 83/11, 1200, Brussels, Belgium.
Kohei ShitaraDepartment of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, National Cancer Center Hospital East, Chiba, Japan.
Anna Dorothea WagnerDepartment of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
Stefanie SchrauwenEuropean Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue E, Mounier 83/11, 1200, Brussels, Belgium.
Takaki YoshikawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Franco RovielloGeneral Surgery and Surgical Oncology Department, University of Siena, Siena, Italy.
Masanori TokunagaDivision of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Narikazu BokuGastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Michel DucreuxDepartment of Medical Oncology, Gustave Roussy, Villejuif, France.
Masanori TerashimaDivision of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Florian LordickUniversity Cancer Center Leipzig (UCCL), University Hospital Leipzig, Liebigstr. 20, 04103, Leipzig, Germany. florian.lordick@medizin.uni-leipzig.de.
EORTC GITCG Group and JCOG SCGC Group
European Organisation for Research and Treatment of Cancer · BEInstitut Gustave Roussy · FRJohannes Gutenberg University Mainz · DEShizuoka Cancer Center · JPUniversity of Siena · ITKanagawa Prefectural Hospital Organization · JPNational Cancer Center Hospital East · JPUniversity Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of multidisciplinary treatment including surgery for liver metastases from gastric cancer (LMGC) is controversial. Studies to answer this clinical question are increasing in number, but all published data thus far are based on retrospective analyses with limited sample sizes. Thus, the European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group (GITCG) and the Japan Clinical Oncology Group (JCOG) Stomach Cancer Study Group (SCSG) initiated a collaboration to develop an optimal treatment strategy for LMGC. Before planning a prospective study, a questionnaire was sent out to the network members of both groups in June 2016 to clarify current common practice in each region. Sixty-seven sites from 17 countries in the EORTC network and 55 sites from Japan responded. According to the survey, for patients with resectable LMGC without extrahepatic metastases, preoperative chemotherapy followed by resection of both primary (if still in place) and liver lesions was the preferred option for both the synchronous and the metachronous setting. For patients with unresectable LMGC, most of the sites recommended chemotherapy only. In this article, the detailed results of this survey are reported, shedding light on current community practice, and a joint EORTC-JCOG strategy of investigation is delineated.

Indexed as

Antineoplastic AgentsCombined Modality TherapyHealth Care SurveysHumansInternational CooperationLiver NeoplasmsNeoplasms, Multiple PrimaryNeoplasms, Second PrimaryStomach NeoplasmsAntineoplastic AgentsEORTCGastric cancerJCOGLiver metastasesSurgery

Identifiers

PMID28150070
OpenAlexW2585966900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.